期刊文献+

贝前列素钠联合甲钴胺治疗糖尿病心脏自主神经病变疗效观察 被引量:3

Observation about Curative Effect of Beraprost Sodium Combined with Mecobalamin on Cardiac Autonomic Neuropathy in Patients with Diabetes Mellitus
下载PDF
导出
摘要 目的:观察贝前列素钠联合甲钴胺治疗糖尿病并心脏自主神经病变的疗效和安全性。方法:选择糖尿病并心脏自主神经病变住院患者120例随机分为观察组和对照组。两组患者均接受降糖治疗。在此基础上,观察组患者予贝前列素钠联合甲钴胺治疗,对照组给予安慰剂治疗。共治疗12周。治疗前后检查两组患者24h动态心电图,采用动态心电图和心率变异性分析软件分析,包括时域分析和频域分析;检测受试者正中神经传导速度。比较两组疗效及药品不良反应。结果:治疗后,两组患者心脏自主神经功能均较治疗前明显改善(P<0.05);且观察组各项指标均明显优于较对照组(P<0.05)。观察组患者治疗后心脏自主神经功能自觉症状评分明显降低(P<0.05);且明显优于对照组(P<0.05)。观察组总有效率为85.0%,明显高于对照组的45.0%(P<0.05)。结论:甲钻胺联合贝前列素钠治疗心脏自主神经病变疗效肯定,安全性好,值得临床推广应用。 Objective:To observe the efficacy and safetyof beraprost sodium combined with methylcobalamin in treatment of diabetic patients complicated with cardiac autonomic neuropathy.Methods:120 cases of diabetes patients complicated with cardiac autonomic neuropathy were divided into two groups randomly.The patients of two groups were treated with hypoglycemic.The observation group were assigned to accept beraprost sodium combined with mecobalamin for 12 weeks,while the control group were treated only with placebo.The patients of two groups received 24 hours of dynamic ECG before and after treatment.Dynamic ECG and heart rate variability analysis software were used to analyze the time domain analysis and frequency domain analysis.The median nerve conduction velocity was tested.The efficacy and adverse drug reactions between the two groups were compared.Results:After the treatment,the cardiac autonomic nervous function in both two groups were significantly improved than before(P 〈0.05);The indicators in the observation group were significantly better than those in the control group(P 〈0.05).The scores of subjective symptom signicantly decreased after the treatment(P 〈0.05),which was better than the control group(P 〈0.05).The total efficiency of observation group was85.0%,which was significantly higher than the control group's 45.0%(P 〈0.05).Conclusion:The curative effect of the combination of the amine and the sodium in the treatment of cardiac autonomic neuropathy was better.Its security was good,and it was worth popularizing and applying.
作者 任诗佳 林肖峰 刘文华 Ren Shijia Lin Xiaofeng Liu Wenhua(Taizhou First People' s Hospital, Taizhou 318020, Zhejiang, China)
出处 《药物流行病学杂志》 CAS 2016年第10期612-615,631,共5页 Chinese Journal of Pharmacoepidemiology
关键词 贝前列素钠 甲钻胺 糖尿病 心脏自主神经病变 心率变异性 Beraprost sodium Mecobalamin Diabetes Cardiovascular autonomic neuropathy Heart rate varia bility
  • 相关文献

参考文献5

二级参考文献287

  • 1Desiree Wanders,Eric P Plaisance,Robert L Judd.Pharmacological effects of lipid-lowering drugs on circulating adipokines[J].World Journal of Diabetes,2010,1(4):116-128. 被引量:5
  • 2黎雅清,李路.2型糖尿病患者心率变异度影响因素分析[J].中国糖尿病杂志,2007,15(3):161-163. 被引量:6
  • 3Bril V.Current treatment of diabetic neuropathy.Can J Diabetes Care,2002,24 (Suppl 2):67-75.
  • 4Forouzandeh F,Aziz Ahari A,Abolhasani F,et al.Comparison of different screening tests for detecting diabetic foot neuropathy.Acta Neurol Scand,2005,112:409-413.
  • 5Meijer JW,Bosma E,Lefrandt JD,et al.Clinical diagnosis of diabetic polyneuropathy with the diabetic neuropathy symptom and diabetic neuropathy examination scores.Diabetes Care,2003,26:697-701.
  • 6Bril V,Perkins BA.Validation of the Toronto clinical scoring system for diabetic polyneuropathy.Diabetes Care,2002,25:2048-2052.
  • 7Quattrini C,Jeziorska M,Malik RA,et al.Small fiber neuropathy in diabetes:chnical consequence and assessment.Int J Low Extrem Wounds,2004,3:16-21.
  • 8Bansal V,Kalita J,Misra UK.Diabetic neuropathy.Postgrad Med J,2006,82:95-100.
  • 9Miranda-Palma B,Basu S,Mizel MD,et al.The monofilament as the gold standard for foot ulcer risk screening:a reappraisal (Abstract).Diabetes,2003,52 (Suppl 1):A63.
  • 10Kamei N,Yamane K,Nakanishi S,et al.Effectiveness of Semmes-Weinstein monofilament examination for diabetic peripheral neuropathy screening.J Diabetes Complications,2005,19:47-53.

共引文献218

同被引文献25

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部